Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amyris Inc (NQ: AMRS )

11.29 USD +0.84 (+8.04%)
Official Closing Price Updated: 7:53 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Amyris Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Amyris Ranked Among World's Top Social And Environmental Impact Companies By Real Leaders®️
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural... 
From PR Newswire
Amyris Creates Partnership With Jonathan Van Ness To Launch Leading Clean Haircare Brand
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural... 
From PR Newswire
Amyris To Launch Its Biossance TM Clean Beauty Brand In China Through Partnership With Superordinary
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural... 
From PR Newswire
Thinking about buying stock in Amyris, Nio, Plug Power, TOP Ships, or Advanced Micro Devices?
InvestorsObserver issues critical PriceWatch Alerts for AMRS, NIO, PLUG, TOPS, and AMD. 
From PR Newswire
Amyris Announces Bonsucro Certification Sustainable Sugarcane Production For Clean Ingredients
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural... 
From PR Newswire
SHAREHOLDER ALERT: Amyris, Inc. (NASDAQ: AMRS) Officers and Directors Under Investigation for Possible Breaches of Fiduciary Duty
Schubert Jonckheer & Kolbe LLP is investigating potential derivative claims on behalf of shareholders of Amyris, Inc. (NASDAQ: AMRS) related to the company's overstatements regarding future royalty... 
From PR Newswire
Amyris Closes $50 Million Strategic Transaction
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural... 
From PR Newswire
Thinking about buying stock in CNS Pharmaceuticals, DermTech, Ampio Pharmaceuticals, Surface Oncology, or Amyris?
InvestorsObserver issues critical PriceWatch Alerts for CNSP, DMTK, AMPE, SURF, and AMRS. 
From PR Newswire
Amyris Hosts Successful First Session Of Its Virtual Investor Mini-Series
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural... 
From PR Newswire
Purecane, the Revolutionary Sweetener Derived from Sugarcane, Wins 2020 Popular Science Best of What's New Award
Product recognized as one of the "100 greatest innovations of 2020" 
From PR Newswire
Amyris Launches Virtual Investor Mini-Series
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural... 
From PR Newswire
Amyris Delivers Record Black Friday Sales
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural... 
From PR Newswire
Amyris To Present at Evercore ISI's 3rd Annual HealthCONx Conference on December 3, 2020
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today... 
From PR Newswire
Amyris, Inc. Reports Third Quarter 2020 Financial Results
Record Product Revenue, Lower Cash Operating Expense, and Expanded Gross Margins 
From PR Newswire
Amyris And Rosie Huntington-Whiteley Announce Creation Of New Clean Beauty Brand And Business Partnership
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, and... 
From PR Newswire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors 
From Business Wire News Releases
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors 
From Business Wire News Releases
Amyris To Host Third Quarter 2020 Financial Results Conference Call On November 5
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today... 
From PR Newswire
Amyris and The Infectious Disease Research Institute Enter into Exclusive License for Novel RNA Vaccine Platform, Beginning with COVID-19 Vaccine
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today... 
From PR Newswire
Amyris and Arzeda Enter into Development Collaboration Agreement
Synergistic technology platforms being leveraged to accelerate development of high value ingredients 
From PR Newswire
Kaskela Law LLC Announces Stockholder Investigation of Amyris, Inc. (AMRS) and Encourages Long-Term Investors to Contact the Firm
Kaskela Law LLC is investigating Amyris, Inc. ("Amyris or the "Company") (NASDAQ: AMRS) on behalf of the Company's stockholders. 
From PR Newswire
The Law Offices of Frank R. Cruz Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors
The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Amyris, Inc (“Amyris” or the “Company”) (NASDAQ: AMRS) concerning whether the board breached its... 
From Business Wire News Releases
Amyris Delivering Sustainable Alternative To Shark Squalene Adjuvant - Enabling Vaccines For All With No Sharks Killed
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today... 
From PR Newswire
Amyris' Pipette Clean Baby Brand Selected By Alibaba For Accelerated Entry Into China For Singles' Day Sales
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today... 
From PR Newswire
Amyris Continues Market Adoption Of Its Sweetener With Approval By Health Canada
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today... 
From PR Newswire
Amyris to Provide Business Overview And Update On Current Affairs At H.C. Wainwright 22nd Annual Global Investment Conference Today
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today... 
From PR Newswire
Amyris Responds To LAVVAN's Filing Of Lawsuit On September 10, 2020
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients,... 
From PR Newswire
LAVVAN, Inc. Files $881 Million Federal Lawsuit Against Amyris, Inc. For Patent Infringement and Trade Secret Misappropriation
Lawsuit Alleges Amyris Wrongfully Used Intellectual Property Licensed Exclusively to LAVVAN and Misappropriated Trade Secrets to Compete Against Its Partner 
From PR Newswire
Amyris to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today... 
From PR Newswire
Amyris Scales First Fermentation-Based Cannabinoid
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today... 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
X